Citation

Whyte I, Buckley N, Carter G, House A, Sheldon T, Freemantle N, Gram LF, Kragh-Sorensen P, Isacsson G, Bergman U, Bernadt M, Hammill R, Gunnell D, Fletcher AP, Jick SS, Jick H. Br. Med. J. Int. Ed. 1995; 311(6996): 55-57.

Copyright

(Copyright © 1995, British Medical Association, Publisher BMJ Publishing Group)

DOI

unavailable

PMID

unavailable

Abstract

[Abstract unavailable]

Language: en

Keywords

human; suicide; depression; schizophrenia; mortality; risk; antidepressant agent; statistical analysis; fluoxetine; moclobemide; serotonin uptake inhibitor; priority journal; letter; dosulepin; flupentixol; drug choice; methodology; drug efficacy; cost effectiveness analysis